AstraZeneca Hits Mylan With Patent Suit Over Cancer Generic
Pharmaceutical giant AstraZeneca hit generic-drug maker Mylan Inc. with a patent infringement suit in New Jersey federal court Monday, aiming to halt production of a generic version of the breast cancer...To view the full article, register now.
Already a subscriber? Click here to view full article